🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with thousands of members share comparison images, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have warned that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.

Several experts said the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.

Some content creators try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer laws, risking fines, legal action or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the platform has taken down problematic material and prohibited related keywords and query recommendations. The organization said it was committed to keeping the service safe and investing in strengthening compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or injecting at residence.

Within minutes of entering one community, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Product Information and Costs

Within these communities, posts display dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.